Department of Psychology, University of North Carolina at Greensboro, 1100 W. Market Street, Greensboro, NC 27402, USA.
Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1189-99. doi: 10.1002/ajmg.b.31090.
The purpose of this meta-analysis was to examine whether association studies between attention deficit/hyperactivity disorder (AD/HD) and the dopamine receptor 4 gene 7-repeat (DRD4 7R) allele vary systematically based on study characteristics. A total of 27 empirical studies with 28 distinct samples using either case-control or family-based association analyses were included. Consistent with previous meta-analytic work [Gizer et al. (2009), Hum Genet 126:51-90], the DRD4 7R allele was associated with AD/HD across studies (OR = 1.33; 95% CI = 1.16-1.53, z = 4.04, P = 0.00005) and there was significant systematic variability among studies (Q = 54.24; P = 0.001; I(2) = 50.22). To account for the variability among studies, sample and study level covariates were examined. No differences in overall effect size emerged between family-based and case-control studies. However, the risk allele frequency in the control population accounted for a significant portion of the variance in overall effect size within case-control studies. In addition, evidence for the association between the DRD4 7R allele and distinct AD/HD subtypes emerged across family-based and case-control studies. The proportion of AD/HD, combined type individuals within the AD/HD sample was associated with a significant increase in the magnitude of association between the DRD4 7R allele and AD/HD. Conversely, an increase in the proportion of AD/HD, predominantly inattentive type individuals within the AD/HD sample was associated with a decrease in study effect size. Implications regarding AD/HD etiological and phenotypic heterogeneity are discussed.
本荟萃分析的目的是检验注意力缺陷多动障碍(AD/HD)与多巴胺受体 4 基因 7 重复(DRD4 7R)等位基因之间的关联研究是否基于研究特征系统地变化。共有 27 项使用病例对照或基于家庭的关联分析的实证研究,包括 28 个不同的样本。与之前的荟萃分析工作一致[Gizer 等人(2009),人类遗传学 126:51-90],DRD4 7R 等位基因与 AD/HD 有关(OR = 1.33;95%CI = 1.16-1.53,z = 4.04,P = 0.00005),并且研究之间存在显著的系统性差异(Q = 54.24;P = 0.001;I(2) = 50.22)。为了解释研究之间的差异,检查了样本和研究水平的协变量。基于家庭和病例对照的研究之间的总体效应大小没有差异。然而,在病例对照研究中,对照人群中的风险等位基因频率解释了总体效应大小差异的很大一部分。此外,在基于家庭和病例对照的研究中都出现了 DRD4 7R 等位基因与不同 AD/HD 亚型之间的关联证据。AD/HD 样本中 AD/HD ,混合型个体的比例与 DRD4 7R 等位基因与 AD/HD 之间的关联程度显著增加有关。相反,AD/HD 样本中 AD/HD ,主要注意力不集中型个体的比例增加与研究效应大小的降低有关。讨论了 AD/HD 病因学和表型异质性的含义。